Skip to main content

Roll out of the COVID:19 vaccine programme

Inquiry

This inquiry follows on from our February 2021 report on the development and rollout of the first vaccines in the UK

The Committee will question senior officials at DHSC, NHS England and the UK Health Security Agency on how well placed the government is to meet its full objectives for the COVID-19 vaccine programme, including:

  • progress with the COVID-19 vaccines programme since the NAO last reported in December 2020;
  • the drivers of success in the first phases of the mass roll-out: the rollout of first and second doses to all priority groups and all adults, and the rollout of first doses to 12-17 year olds
  • the future aims and challenges for the vaccines programme as the first phases of roll-out come to an end; and
  • the risks to sustainability and delivering value for money in future, including in phases yet to be evaluated such as the rollout of boosters, second doses for 12-17 year olds, and vaccines for younger children

If you have evidence on these issues please submit it here by Monday 21 March 2022.

This inquiry is no longer accepting evidence

The deadline for submissions was Monday 21 March 2022.

Reports, special reports and government responses

View all reports and responses
Eleventh Report - The rollout of the COVID-19 vaccine programme in England
Inquiry Roll out of the COVID:19 vaccine programme
HC 258
Report
Response to this report
Correspondence from Sir Chris Wormald, Permanent Secretary of the Department of Health and Social Care, re Treasury minute progress report for TM11 - Rollout of vaccine programme, dated 15 May 2023
Correspondence
Response to this report
Treasury minutes: Government response to the Committee of Public Accounts on the Eleventh report from Session 2022-23
HC 258
Government Response
Correspondence from Amanda Pritchard, Chief Executive, NHS England, re House of Commons Committee of Public Accounts Eleventh Report of Sessions 2022- 2023: The rollout of the COVID-19 vaccine programme in England, dated 31 October 2022
Inquiry Roll out of the COVID:19 vaccine programme
Correspondence
Correspondence from Amanda Pritchard, Chief Executive, NHS, re Follow up to the Public Accounts Committee oral evidence session on COVID-19 vaccines – 28 March 2022, dated 22 April 2022
Inquiry Roll out of the COVID:19 vaccine programme
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
28 March 2022
Inquiry Roll out of the COVID:19 vaccine programme
Oral Evidence
Anonymised (RCP0001)
International Longevity Centre UK (ILC) (RCP0002)
Professor Carmen Clayton (Professor in Family and Cultural Dynamics at Leeds Trinity University), Rafe Clayton , and Marie Potter (RCP0003)

Contact us

  • Email: pubaccom@parliament.uk
  • Phone: 020 7219 8480 (strictly media enquiries only – contact us via our email for general enquiries)
  • Address: Public Accounts Committee, House of Commons, London, SW1A 0AA